Document is current
Any future updates will be listed below
-
Authors
How, Jeffrey A. https://orcid.org/0000-0003-1446-9574
Jazaeri, Amir A.
Westin, Shannon N. https://orcid.org/0000-0002-1922-0156
Lawson, Barrett C.
Klopp, Ann H.
Soliman, Pamela T.
Lu, Karen H.
- License Information
-
More Information
Article History
Accepted: 30 July 2024
First Online: 28 August 2024
Competing interests
: A.A.J. has acted as an adviser and/or consultant to Agenus, Eisai, Genentech-Roche, Gerson Lehrman Group, Guidepoint, Iovance, Macrogenics, NuProbe, PACT Pharma and Simcere; has received research grants from Aravive, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Immatics US, Iovance, Merck and Pfizer, and stock/stock options in AvengeBio. S.N.W. has acted as a consultant and/or adviser to Agenus, Astrazeneca, CIrculogene, Clovis Oncology, Eisai GlaxoSmithKline/Tesaro, Merck, Novartis, Pfizer, Roche/Genentech and Zentalis; and has received research funding from Arqule, Astrazeneca, Bayer, Clovis Oncology, Cotinga Pharmaceuticals, GlaxoSmithKline/Tesaro, GOG Foundation, Novartis and Roche/Genentech. The other authors declare no competing interests.
